Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

Launched by IRAN UNIVERSITY OF MEDICAL SCIENCES · Aug 4, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new treatment for people suffering from dry eye syndrome. Specifically, the study is looking at a type of eye drop made from stem cells that could help reduce symptoms like burning, itching, or the feeling of something stuck in the eye. The main goal is to see if these eye drops are safe and effective for individuals with moderate to severe dry eye.

To participate, you need to be between the ages of 18 and 70 and have experienced bothersome dry eye symptoms. However, there are some factors that might prevent you from joining, such as having had eye surgery in the past or certain health conditions that affect your immune system. If you decide to take part in the trial, you can expect regular check-ins and assessments to monitor your symptoms and how you respond to the treatment. This trial is currently recruiting participants, so it's a good time to learn more if you're interested in finding relief from dry eye symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with complaints of burning or itching or feeling of a foreign body in the eye
• • Moderate and severe dry eye severity
• • Age between 18-70 years
• Exclusion Criteria:
• • Previous history of eye surgery
• • Any disease that suppresses the immune system
• • Pregnancy and breastfeeding
• • Eyelid abnormalities
• • Use of eye drops in the past year except artificial tears and lubricating ointments
• • Use of systemic drugs that affect the tear film in last three months
• • Use of contact lenses in the last three months